Neon drop · Free ship $75+ · Enter the grid
Login Register
Signal · Product Feed
CUDC-101 - HDAC/EGFR/HER2 Inhibitor. CAS# 1012054-59-9 Catalog No.:M60092-2S Shelf Life: ≥12 months if
CUDC-101 - HDAC/EGFR/HER2 Inhibitor. CAS# 1012054-59-9 Catalog No.:M60092-2S Shelf Life: ≥12 months if
CUDC-101 - HDAC/EGFR/HER2 Inhibitor. CAS# 1012054-59-9 Catalog No.:M60092-2S Shelf Life: ≥12 months if
CUDC-101 - HDAC/EGFR/HER2 Inhibitor. CAS# 1012054-59-9 Catalog No.:M60092-2S Shelf Life: ≥12 months if

CUDC-101 - HDAC/EGFR/HER2 Inhibitor. CAS# 1012054-59-9 Catalog No.:M60092-2S Shelf Life: ≥12 months if

SKU: 52855111313

4.3
PLN42.00 PLN73.00

Pay in 4 interest-free payments of $10.50 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

Live Spec

CUDC-101 - HDAC/EGFR/HER2 Inhibitor. CAS# 1012054-59-9 Catalog No.:M60092-2S Shelf Life: ≥12 months ifCUDC 101, CAS No. 1012054 59 9, is a potent multi target inhibitor targeting HDAC, EGFR and HER2 with IC50 of 4. 4 nM, 2. 4 nM, and 15. 7 nM, respectively. It is specific for class I and class II HDACs, not for class III Sir type HDACs, and has > 50 fold selectivity against other protein kinases. CUDC 101 displays broad antiproliferative activity in many human cancer cell types with IC50 of 0. 04 0. 80 M, exhibiting a higher potency than erlotinib,

Store: nyherosfund.org · Domain: nyherosfund.org

Description

Shelf Life: ≥12 months if stored properly

Chemical Name: N-(2

Growth response of human colorectal tumour cell lines to treatment with afatinib (BIBW2992)

and CDK1 with IC50 of 35 nM

CUDC-101 - HDAC/EGFR/HER2 Inhibitor. CAS# 1012054-59-9 Catalog No.:M60092-2S Shelf Life: ≥12 months ifCUDC 101, CAS No. 1012054 59 9, is a potent multi target inhibitor targeting HDAC, EGFR and HER2 with IC50 of 4. 4 nM, 2. 4 nM, and 15. 7 nM, respectively. It is specific for class I and class II HDACs, not for class III Sir type HDACs, and has > 50 fold selectivity against other protein kinases. CUDC 101 displays broad antiproliferative activity in many human cancer cell types with IC50 of 0. 04 0. 80 M, exhibiting a higher potency than erlotinib,

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products